Present study reported for the first time about a new, simple, fast, robust and accurate, routine HPLC method for simultaneous quantification of Flumethasone Pivalate and salicylic acid in bulk powder and in an ointment dosage form. Chromatographic analysis was carried out on Calixarene stationary phase after two steps extraction. Water was used in first step for extraction of salicylic acid because the excipients in the ointment interfere with salicylic acid determination upon extraction with organic solvent. After that the residue was extracted with organic solvent for to determine the robustness of the method. The proposed method was found to be robust.
Introduction
Salicylic acid (SA), 2-hydroxybenzoic acid (Fig 1) , is a keratolytic agent and is the active ingredient of Willow bark 1, 2 . It is used for treatment of many dermatologic conditions From the literature survey, it could be concluded that many analytical techniques have been established for determination of each of SA [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and FP [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] alone or in combination with other drugs. Previously described methods for determination of SA include HPLC [6] [7] [8] [9] [10] [11] [12] , electrochemical [12] [13] [14] [15] [16] [17] [18] and spectrophotometric methods 19 . HPLC [22] [23] [24] [25] , electrochemical [26] [27] and spectrophotometric methods 28 were applied for determination of FP. SA was analyzed in presence of acetyl salicylic acid 6, 14, 15 , cold medicaments 7 , other analgesics 8 or corticosteroids other than FP such as mometsone furoate 9 and tolnaftate 11 . FP was previously analyzed in combination with other corticosteroids 24, 25, 27 or with clioquinol 28 . Calixarene bonded stationary phases are relatively new HPLC-stationary phases.
Calixarenes are macrocyclic molecules. They consist of phenol units linked by alkylidene groups 29, 30 . There are several reported applications on Calixarenes as HPLC-stationary phases [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] .
Fig 1: Chemical structures of the analytes
Their ability to interact with analytes through different mechanisms is the advantage making Calixarene stationary phases superior to the ºC, 20 μL of samples was injected per run and eluates were detected using a diode array detector at λ= 240 nm.
Preparation of stock and standard working solutions
150 and 10 mg of SA and FP respectively, were dissolved separately in 100 mL mobile phase (ACN/H 2 O, 70:30 v/v) to give 1.5 mg mL -1 and 0.1 mg mL -1 stock solutions of SA and FP, respectively.
The standard working solutions were prepared by making serial dilution of aliquots of the stock solutions using mobile phase to obtain the required concentrations ranging from 0.0625 to 100 µg mL -1 for both analytes. By plotting the peak areas obtained at wavelength 240 nm versus the corresponding injected concentrations for each analyte, the calibration graph was constructed. For the range of linearity and linear equations see table 1.
Sample preparation (Two steps extraction procedure)
It was found that when any organic solvent such as methanol, ACN or ethanol was used for extraction of the active constituents from the ointment, some additives were extracted. These additives interfered with SA as their peaks co-eluted with SA peak. There were two solutions to overcome this problem. The first was to apply gradient elution mode but upon application, it needed too long time for separation of SA from these additives adding to the time consumed for re-conditioning of the stationary phase before each run. This is why the second solution was tried, which was the two steps extraction procedure. It includes extraction of SA with bi-distilled water. Bidistilled water led to extraction of SA only, and this overcame the interference of the additives in the ointment. And then extraction of FP from residue using mobile phase took place, followed by isocratic elution mode for each extract, which save the time in comparison with the gradient elution mode. Several columns of different types were examined for separation. Calixarene "Caltrex AΙ ® " column gave the best separation and shortest retention times, so it was used as stationary phase in this study. 
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Results

Method optimization
Conditions affecting the chromatographic separation and determination of both analytes were carefully studied in order to select the most suitable chromatographic system. The choice was based on the best resolution between additives peak and FP peak in a reasonable time. At the beginning, methanol was applied as organic modifier but it did not give good separation. This is why ACN was examined as the organic modifier. ACN% in mobile phase less than 70% resulted in elongation of run time without any improvement of separation. When the ACN% was raised to greater than 70% the retention times shortened but there was co-elution between additives and FP. Thus, 70% ACN was selected as organic modifier percentage in all runs. Detection was carried out by 240 nm because it gave better results than 254 nm. When buffered mobile phase was used instead of H 2 O there was no change in the separation, and this is why H 2 O without any salts was applied as aqueous part of mobile phase. The retention times for SA and FP were 0.6440.025 and 1.3570.009 min, respectively.
Method validation
Validation of the proposed method was done according to ICH guidelines 50 concerning with linearity, precision, specificity, limits of quantification and detection, accuracy and robustness.
Linearity
Linear relationships were obtained between the peak areas of the studied drugs and the concentration ranges mentioned in (Table 1) .
High values for (R 2 ) were obtained. Statistical parameters and linearity results are illustrated in (Table 1) .
Limits of detection and quantitation
The limit of detection (LOD) defined as the injected quantity giving S/N of 3 (signal to noise in terms of peak height) and the limits of quantification (LOQ) defined as the injected quantity giving S/N of 10 were found to be 0.125 and 0.250 µg mL -1 respectively for both analytes (Table 1) .
Precision
Precisions, intra-and inter-day, expressed as percentage relative standard deviation RSD (%), were usually lower than 2.98%
indicating the high precision of the method (Table 2 ). Intra-day precision was assessed by injection of the standard solution at two concentrations five times during a day. The same was done for interday precision test except that the injection of the samples was every day for five days.
Accuracy
The accuracy of the proposed method was determined by applying the same procedure for determination of the studied drugs in the ointment dosage form. Analysis of Locasen ® ointment showed high accuracy with good recoveries of 98.99 ± 0.66% and 97.50 ± 1.33%
for SA and FP, respectively (Table 3 ). In addition, the results obtained using the proposed HPLC method was statistically compared with those obtained with the reported HPLC methods 7, 23 .
The results in table 3 showed that the calculated t and f values are less than the corresponding tabulated ones. This proves that there is no significant difference between the proposed method and reference ones, regarding accuracy and precision.
Specificity
Upon the two steps extraction method there was no interference from the excipients. No additional peaks were co-eluted with analyte peaks. This evidences the ability of the method to assess the analytes of interest in ointment without any interference from excipients or co-formulated additives and indicates the specificity of the method (Fig. 2) .
Robustness
Small variations in chromatographic conditions such as flow rate, ACN%, detection wavelength, temperature and injection volume (Table 4) were done to study the robustness of the proposed method. The slight variations in the examined conditions had no significant effect on peaks area and shape. Changes in the flow rate and ACN% have greater effects than the changes in the other factors. 
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